aspartic acid has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kopin, IJ; Marini, AM; Schwartz, JP | 1 |
| Chan, P; Di Monte, DA; Langston, JW | 1 |
| Kemp, CA; Kirton, SB; St-Gallay, S; Sutcliffe, MJ; Tomkinson, NP | 1 |
| Hadjiconstantinou, M; Neff, NH; Podell, M; Smith, MA | 1 |
| Blezer, EL; Jongsma, MJ; Olivier, B; Philippens, IH; van Vliet, SA; van Vlieta, SA; Vanwersch, RA | 1 |
| Choe, BY; Choi, CB; Choi, WS; Jahng, GH; Kim, HY; Kim, SY; Lee, SH; Ryu, KN; Yang, DM; Yim, SV | 1 |
6 other study(ies) available for aspartic acid and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
The neurotoxicity of 1-methyl-4-phenylpyridinium in cultured cerebellar granule cells.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Aspartic Acid; Cells, Cultured; Cerebellum; Designer Drugs; Excitatory Amino Acid Antagonists; Glutamic Acid; Granulocytes; Monoamine Oxidase; Neurotoxins; Osmolar Concentration; Time Factors | 1989 |
Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutamate and aspartate in the mouse brain.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aspartic Acid; Brain Chemistry; Deoxyglucose; Energy Metabolism; Glutamic Acid; Male; Mazindol; Mice; Mice, Inbred C57BL; Receptors, N-Methyl-D-Aspartate; Selegiline | 1994 |
Impact of incorporating the 2C5 crystal structure into comparative models of cytochrome P450 2D6.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amino Acid Sequence; Animals; Aspartic Acid; Bacteria; Binding Sites; Codeine; Crystallography, X-Ray; Cytochrome P-450 CYP2D6; Models, Molecular; Molecular Sequence Data; Molecular Structure; Principal Component Analysis; Protein Binding; Protein Folding; Protein Structure, Secondary; Reproducibility of Results; Sequence Alignment; Substrate Specificity | 2002 |
Proton magnetic resonance imaging and spectroscopy identify metabolic changes in the striatum in the MPTP feline model of parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aspartic Acid; Brain; Cats; Choline; Corpus Striatum; Creatine; Disease Models, Animal; Disease Progression; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Neurologic Examination; Pargyline; Parkinsonian Disorders; Predictive Value of Tests; Protons; Tyrosine 3-Monooxygenase | 2003 |
Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aspartic Acid; Benzhydryl Compounds; Biomarkers; Brain; Callithrix; Disease Models, Animal; Dopamine; Drug Administration Schedule; Immunohistochemistry; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Modafinil; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Parkinsonian Disorders; Phosphocreatine; Predictive Value of Tests; Reproducibility of Results; Substantia Nigra; Treatment Outcome; Tyrosine 3-Monooxygenase | 2008 |
Assessment of metabolic changes in the striatum of a MPTP-intoxicated canine model: in vivo ¹H-MRS study of an animal model for Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aspartic Acid; Choline; Corpus Striatum; Creatine; Disease Models, Animal; Dogs; Female; Humans; Male; MPTP Poisoning; Tissue Distribution | 2011 |